NEW YORK, Aug. 27, 2015 /PRNewswire/ -- Virtus ETF
Solutions announced today that the net asset value ("NAV") reported
on August 25 was incorrect due to a
technical malfunction experienced by the fund accounting agent,
which calculates the NAV. The correct NAVs are provided below. NAV
per share does not represent the market price at which an investor
may trade shares of the fund on the NYSE or the NASDAQ. The closing
market price on that date remains unchanged.
|
ETF
Ticker
|
ETF
Name
|
Originally
Published NAV Per Share ($)
|
Adjusted NAV Per
Share ($)
|
Difference
($)
|
Difference
(%)
|
|
AMZA
|
InfraCap MLP
ETF
|
14.41
|
15.58
|
1.16
|
8.08%
|
|
TUTT
|
Tuttle Tactical
Management U.S. Core ETF
|
22.61
|
22.02
|
-0.59
|
-2.62%
|
|
BBC
|
BioShares
Biotechnology Clinical Trials Fund
|
29.99
|
29.23
|
-0.75
|
-2.51%
|
|
NFLT
|
Newfleet Multi-Sector
Unconstrained Bond ETF
|
25.00
|
24.99
|
-0.01
|
-0.02%
|
|
BBP
|
BioShares
Biotechnology Products Fund
|
31.35
|
30.39
|
-0.95
|
-3.04%
|
|
TUTI
|
Tuttle Tactical
Management Multi-Strategy Income ETF
|
23.71
|
23.60
|
-0.11
|
-0.45%
|
About Virtus ETF Solutions
Virtus ETF Solutions, formerly ETF Issuer Solutions, an
affiliate of Virtus Investment Partners, operates a multi-manager
ETF platform, providing investors access to differentiated
investment capabilities from select subadvisers.
Logo -
http://photos.prnewswire.com/prnh/20121031/NE03346LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/virtus-etf-solutions-announces-revised-net-asset-value-information-for-listed-etfs-300134178.html
SOURCE Virtus ETF Solutions